Who owns Xbiotech?
- Ticker: XBIT
- CUSIP Number: 98400h102
Tip: Access positions for across all investors
Analyze quarterly positions in Xbiotech with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Xbiotech stock
Who bought or sold Xbiotech this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 300k | $716k | -63% | Dec 2025 |
|
| BlackRock | 293k | $689k | 2% | Mar 2026 |
|
| Geode Capital Management | 231k | $543k | 4% | Mar 2026 |
|
| Vanguard Capital Management | 201k | $472k | 100% | Mar 2026 |
|
| Rbf Capital | 199k | $467k | 0% | Mar 2026 |
|
| Morgan Stanley | 166k | $389k | 1% | Mar 2026 |
|
| Millennium Management | 106k | $248k | -22% | Mar 2026 |
|
| Vanguard Fiduciary Trust | 92k | $215k | 100% | Mar 2026 |
|
| Bridgeway Capital Management | 90k | $214k | 50% | Dec 2025 |
|
| Northern Trust | 76k | $183k | -6% | Dec 2025 |
|
| State Street Corporation | 73k | $175k | 8% | Dec 2025 |
|
| Jane Street | 60k | $141k | -14% | Mar 2026 |
|
| Empowered Funds | 60k | $140k | 0% | Mar 2026 |
|
| Squarepoint Ops | 41k | $97k | -36% | Mar 2026 |
|
| Bank of New York Mellon | 39k | $93k | -19% | Mar 2026 |
|
| Bank of America Corporation | 37k | $86k | 100% | Mar 2026 |
|
| Dimensional Fund Advisors | 36k | $85k | -29% | Mar 2026 |
|
| Connor, Clark & Lunn Investment Management | 29k | $67k | -5% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 27k | $64k | 1% | Mar 2026 |
|
| National Bank Of Canada /fi/ | 25k | $59k | 0% | Dec 2025 |
|
| XTX Topco | 22k | $52k | 44% | Dec 2025 |
|
| Qube Research & Technologies | 21k | $49k | -32% | Dec 2025 |
|
| American Century Companies | 19k | $45k | 0% | Dec 2025 |
|
| TNB Financial | 13k | $32k | 0% | Dec 2025 |
|
| Pinnacle Financial Partners | 12k | $28k | 100% | Dec 2025 |
|
| Vanguard Global Advisers | 7.0k | $17k | 100% | Mar 2026 |
|
| UBS Group | 5.0k | $12k | -1% | Mar 2026 |
|
| Royal Bank of Canada | 1.2k | $0 | -57% | Mar 2026 |
|
| Rhumbline Advisers | 928.00 | $2.2k | 0% | Mar 2026 |
|
| McIlrath & Eck | 753.00 | $1.8k | 0% | Mar 2026 |
|
| FMR | 450.00 | $1.1k | 45% | Dec 2025 |
|
| Jones Financial Companies, L.L | 370.00 | $884.004000 | 0% | Dec 2025 |
|
| Simplex Trading | 67.00 | $160.002700 | -79% | Dec 2025 |
|
| SBI Securities | 37.00 | $87.001800 | 3600% | Mar 2026 |
|
| CWM | 23.00 | $0 | -82% | Dec 2025 |
|
| Larson Financial Group | 21.00 | $50.001000 | 0% | Dec 2025 |
|
| SRS Capital Advisors | 15.00 | $34.999500 | 100% | Mar 2026 |
|
| Caitong International Asset Management | 11.00 | $25.999600 | 100% | Mar 2026 |
|
| Optiver Holding B.V. | 8.00 | $19.000000 | 0% | Mar 2026 |
|
| Barclays | 1.00 | $2.000000 | -100% | Dec 2025 |
|
Who sold out of Xbiotech?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Ameriprise Financial | Dec 2025 | 187k | $446k |
| Citadel Advisors | Dec 2025 | 18k | $44k |
| Goldman Sachs Group | Dec 2025 | 17k | $40k |
| Two Sigma Advisers | Dec 2025 | 16k | $39k |
| Persistent Asset Partners | Dec 2025 | 14k | $32k |
| Two Sigma Securities | Dec 2025 | 10k | $25k |
| Jpmorgan Chase & Co | Sep 2025 | 2.4k | $6.3k |